Melasma can appear as brown, uneven patches across the cheeks, forehead, or upper lip. It is also persistent. A 2022 clinical review in StatPearls describes melasma as a common pigmentary disorder influenced by factors including ultraviolet exposure, hormones, and genetic susceptibility. Its visible impact can be significant, yet treatment response varies between patients.
“Melasma is a chronic, relapsing disorder.” This concise clinical characterization is consistent with the published work of dermatologist Dr. Pearl Grimes, a leading researcher in pigmentary disorders. It matters when evaluating laser devices: a brief reduction in pigmentation does not necessarily mean durable control. Nanosecond and picosecond platforms use different pulse durations and may target pigment differently, but device settings, skin type, operator expertise, and aftercare all affect risk and results. Lasers are not suitable for every patient.
The market is expanding, but market growth is not proof of clinical superiority. Grand View Research estimated the global aesthetic-lasers market at approximately US$1.1 billion in 2023; that figure covers many treatments, not melasma machines alone. This Top 10 Melasma Nanosecond Picosecond Laser Machines guide therefore compares technology, practical features, safety considerations, and the quality of available evidence—not just sales claims. Some specifications are easier to compare than clinical outcomes. That limitation deserves attention. Readers should discuss diagnosis and treatment choices with a qualified dermatologist, since melasma can resemble other pigment conditions and may worsen with poorly selected procedures.
Melasma is a chronic pigment condition that often appears as symmetrical brown or gray patches on the cheeks, forehead, or upper lip. It is more than surface staining: sun exposure, visible light, hormonal changes, and heat may all contribute. The American Academy of Dermatology reports that melasma affects more than five million people in the United States. It can return. Daily broad-spectrum sunscreen and shade remain important, even after a laser session.
Nanosecond and picosecond lasers deliver brief pulses of energy that target pigment, but they are not interchangeable or guaranteed fixes. A dermatologist should assess skin tone, pigment depth, medical history, and previous treatments before selecting a wavelength and settings. Clinical reviews of laser treatment describe improvement in some patients, alongside risks such as irritation, uneven lightening, and recurrence. Darker skin tones may be more vulnerable to post-inflammatory pigmentation.
That matters. A patch may look lighter at first, then darken again after sun exposure.
Treatment planning should therefore include realistic expectations, eye protection, careful follow-up, and continued sun protection. Results vary, and laser treatment is usually considered alongside—not instead of—medical skin care.
Sources: American Academy of Dermatology, “Melasma”; peer-reviewed clinical reviews of laser and light treatments for melasma.